FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026180995> ?p ?o ?g. }

• W2026180995 endingPage "1437" @default.
• W2026180995 startingPage "1432" @default.
• W2026180995 abstract "BACKGROUND Accumulation of mutated p53 in malignant cells can lead to the generation of anti-p53 autoantibodies in the serum and other body fluids of cancer patients. This retrospective study was performed to evaluate the prognostic significance of preoperative serum and ascitic anti-p53 antibodies in advanced ovarian carcinoma. METHODS In 113 ovarian carcinoma patients who presented with significant amounts of ascites, anti-p53 autoantibodies were determined by a highly specific enzyme-linked immunosorbent assay of blood and ascites. Disease free and overall survival of study patients was estimated by the product limit method of Kaplan and Meier. Differences in survival were examined according to criteria of Mantel and Breslow. A multiple regression analysis based on the Cox proportional hazards model was used to determine the independence of prognostic variables. RESULTS Serum and ascitic anti-p53 antibodies were found in 28 (25%) and 21 (19%) of the study patients, respectively. In univariate analysis, detection of anti-p53 antibodies in ascites but not in serum was found to be a sign of unfavorable disease free survival (P < 0.003) and overall survival (P < 0.01). Multivariate analysis revealed that anti-p53 positivity in ascites retained independent significance only in the prediction of adverse progression free survival (P < 0.01). CONCLUSIONS The generation of a humoral immune response against p53 protein in the close tumor environment, as demonstrated by the occurrence of p53 autoantibodies in the ascitic fluid of ovarian carcinoma patients, is associated with poor disease free survival. Cancer 2000;88:1432–7. © 2000 American Cancer Society." @default.
• W2026180995 created "2016-06-24" @default.
• W2026180995 creator A5006608114 @default.
• W2026180995 creator A5034695241 @default.
• W2026180995 creator A5042493804 @default.
• W2026180995 creator A5061545433 @default.
• W2026180995 creator A5069903759 @default.
• W2026180995 creator A5078598033 @default.
• W2026180995 date "2000-03-15" @default.
• W2026180995 modified "2023-09-27" @default.
• W2026180995 title "Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma" @default.
• W2026180995 cites W1927023482 @default.
• W2026180995 cites W1966143946 @default.
• W2026180995 cites W1972392250 @default.
• W2026180995 cites W1987481543 @default.
• W2026180995 cites W2012053348 @default.
• W2026180995 cites W2024646930 @default.
• W2026180995 cites W2034455009 @default.
• W2026180995 cites W2039832404 @default.
• W2026180995 cites W2049731829 @default.
• W2026180995 cites W2059561866 @default.
• W2026180995 cites W2062414686 @default.
• W2026180995 cites W2072319696 @default.
• W2026180995 cites W2074470242 @default.
• W2026180995 cites W2074783999 @default.
• W2026180995 cites W2075847417 @default.
• W2026180995 cites W2078742602 @default.
• W2026180995 cites W2082369433 @default.
• W2026180995 cites W2083190520 @default.
• W2026180995 cites W2099907467 @default.
• W2026180995 cites W2139097918 @default.
• W2026180995 cites W2156266214 @default.
• W2026180995 cites W2156496267 @default.
• W2026180995 cites W2160370110 @default.
• W2026180995 cites W2334088716 @default.
• W2026180995 doi "https://doi.org/10.1002/(sici)1097-0142(20000315)88:6<1432::aid-cncr22>3.0.co;2-8" @default.
• W2026180995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10717627" @default.
• W2026180995 hasPublicationYear "2000" @default.
• W2026180995 type Work @default.
• W2026180995 sameAs 2026180995 @default.
• W2026180995 citedByCount "50" @default.
• W2026180995 countsByYear W20261809952012 @default.
• W2026180995 countsByYear W20261809952013 @default.
• W2026180995 countsByYear W20261809952014 @default.
• W2026180995 countsByYear W20261809952015 @default.
• W2026180995 countsByYear W20261809952016 @default.
• W2026180995 countsByYear W20261809952017 @default.
• W2026180995 countsByYear W20261809952018 @default.
• W2026180995 countsByYear W20261809952021 @default.
• W2026180995 countsByYear W20261809952022 @default.
• W2026180995 crossrefType "journal-article" @default.
• W2026180995 hasAuthorship W2026180995A5006608114 @default.
• W2026180995 hasAuthorship W2026180995A5034695241 @default.
• W2026180995 hasAuthorship W2026180995A5042493804 @default.
• W2026180995 hasAuthorship W2026180995A5061545433 @default.
• W2026180995 hasAuthorship W2026180995A5069903759 @default.
• W2026180995 hasAuthorship W2026180995A5078598033 @default.
• W2026180995 hasBestOaLocation W20261809951 @default.
• W2026180995 hasConcept C10515644 @default.
• W2026180995 hasConcept C121608353 @default.
• W2026180995 hasConcept C126322002 @default.
• W2026180995 hasConcept C143998085 @default.
• W2026180995 hasConcept C159654299 @default.
• W2026180995 hasConcept C163764329 @default.
• W2026180995 hasConcept C203014093 @default.
• W2026180995 hasConcept C2777546739 @default.
• W2026180995 hasConcept C2780427987 @default.
• W2026180995 hasConcept C2780496750 @default.
• W2026180995 hasConcept C3019054536 @default.
• W2026180995 hasConcept C50382708 @default.
• W2026180995 hasConcept C63363279 @default.
• W2026180995 hasConcept C71924100 @default.
• W2026180995 hasConcept C90924648 @default.
• W2026180995 hasConceptScore W2026180995C10515644 @default.
• W2026180995 hasConceptScore W2026180995C121608353 @default.
• W2026180995 hasConceptScore W2026180995C126322002 @default.
• W2026180995 hasConceptScore W2026180995C143998085 @default.
• W2026180995 hasConceptScore W2026180995C159654299 @default.
• W2026180995 hasConceptScore W2026180995C163764329 @default.
• W2026180995 hasConceptScore W2026180995C203014093 @default.
• W2026180995 hasConceptScore W2026180995C2777546739 @default.
• W2026180995 hasConceptScore W2026180995C2780427987 @default.
• W2026180995 hasConceptScore W2026180995C2780496750 @default.
• W2026180995 hasConceptScore W2026180995C3019054536 @default.
• W2026180995 hasConceptScore W2026180995C50382708 @default.
• W2026180995 hasConceptScore W2026180995C63363279 @default.
• W2026180995 hasConceptScore W2026180995C71924100 @default.
• W2026180995 hasConceptScore W2026180995C90924648 @default.
• W2026180995 hasIssue "6" @default.
• W2026180995 hasLocation W20261809951 @default.
• W2026180995 hasLocation W20261809952 @default.
• W2026180995 hasOpenAccess W2026180995 @default.
• W2026180995 hasPrimaryLocation W20261809951 @default.
• W2026180995 hasRelatedWork W2116586212 @default.
• W2026180995 hasRelatedWork W2152657512 @default.
• W2026180995 hasRelatedWork W2160370110 @default.
• W2026180995 hasRelatedWork W2369071334 @default.
• W2026180995 hasRelatedWork W2381462645 @default.

• next